KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Assets Average: 2010-2025

Historic Assets Average for Ionis Pharmaceuticals (IONS) over the last 15 years, with Sep 2025 value amounting to $3.0 billion.

  • Ionis Pharmaceuticals' Assets Average rose 4.26% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 4.26%. This contributed to the annual value of $3.0 billion for FY2024, which is 8.50% up from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Assets Average stood at $3.0 billion for Q3 2025, which was up 3.80% from $2.9 billion recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Assets Average registered a high of $3.0 billion during Q4 2024, and its lowest value of $2.3 billion during Q1 2021.
  • Its 3-year average for Assets Average is $2.9 billion, with a median of $2.9 billion in 2025.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Assets Average dropped by 26.66% in 2021, and later rose by 21.05% in 2023.
  • Quarterly analysis of 5 years shows Ionis Pharmaceuticals' Assets Average stood at $2.5 billion in 2021, then decreased by 1.41% to $2.5 billion in 2022, then increased by 19.54% to $3.0 billion in 2023, then climbed by 2.71% to $3.0 billion in 2024, then rose by 4.26% to $3.0 billion in 2025.
  • Its last three reported values are $3.0 billion in Q3 2025, $2.9 billion for Q2 2025, and $2.9 billion during Q1 2025.